36874025|t|Crebanine induces ROS-dependent apoptosis in human hepatocellular carcinoma cells via the AKT/FoxO3a signaling pathway.
36874025|a|Background: Hepatocellular carcinoma (HCC), as an aggressive cancer with a high mortality rate, needs high-efficiency and low-toxicity drug therapy. Natural products have great potential as candidate lead compounds for the development of new HCC drugs. Crebanine is an isoquinoline alkaloid derived from Stephania with various potential pharmacological effects such as anti-cancer. However, the molecular mechanism underlying crebanine-induced liver cancer cells apoptosis has not been reported. Here, we investigated the effect of crebanine on HCC and identified a potential mechanism of action. Methods: In this paper, we intend to detect the toxic effects of crebanine on hepatocellular carcinoma HepG2 cells through a series of in vitro experiments, including detecting the effects of crebanine on the proliferation of HepG2 cells using the CCK8 method and plate cloning assay, observing the growth status and morphological changes of crebanine on HepG2 cells by inverted microscopy; and using the Transwell method to determine the the effect of crebanine on the migration and invasion ability of HepG2 cells; using Hoechst 33258 assay to stain cancer cells, thus observing the effect of crebanine on the morphology of HepG2 apoptotic cells, and detecting the apoptotic state and level of HepG2 cells by flow cytometry; using ROS kit and JC-1 assay kit to detect the changes of reactive oxygen species and mitochondrial membrane potential of HepG2 The immunofluorescence assay was taken to verify whether crebanine had an effect on the expression of p-FoxO3a in cancer cells; the Wetern blot assay was also used to examine the effect of crebanine on proteins related to the mitochondrial apoptotic pathway and its effect on the regulation of the relative protein expression of AKT/FoxO3a axis; after this, NAC and AKT inhibitor LY294002 were used to cells were pretreated with NAC and AKT inhibitor LY294002, respectively, in order to further validate the inhibitory effect of crebanine. Results: It was shown that crebanine effectively inhibited the growth and capacity of HepG2 cells migration and invasion in a dose-dependent manner. Furthermore, the effect of crebanine on the morphology of HepG2 cells was observed through microscopy. Meanwhile, crebanine induced apoptosis by causing reactive oxygen species (ROS) burst and mitochondrial membrane potential (MMP) disrupt. We found that crebanine could down-regulate Bcl-2 and up-regulate Bax, cleaved-PARP, cleaved-caspase-3 and cleaved-caspase-9, but these effects were overturned by ROS inhibitor N-acetylcysteine (NAC). Crebanine also down-regulated p-AKT and p-FoxO3a, and the PI3K inhibitor LY294002 significantly enhances this effect. We also found that the expression of AKT/FoxO3a signaling pathway was ROS-dependent. As shown by Western blots, NAC could partially attenuate the inhibitory effect of crebanine on AKT and FoxO3a phosphorylation. Conclusion: Based on our results, our results suggest that crebanine, as a compound with potential anticancer activity, has significant cytotoxic effects on hepatocellular carcinoma,and it likely induces apoptosis via ROS in the mitochondrial pathway and simultaneously affects the biological function of HCC via the ROS-AKT-FoxO3a signaling axis.
36874025	0	9	Crebanine	Chemical	MESH:C061009
36874025	18	21	ROS	Chemical	MESH:D017382
36874025	45	50	human	Species	9606
36874025	51	75	hepatocellular carcinoma	Disease	MESH:D006528
36874025	90	93	AKT	Gene	207
36874025	94	100	FoxO3a	Gene	2309
36874025	132	156	Hepatocellular carcinoma	Disease	MESH:D006528
36874025	158	161	HCC	Disease	MESH:D006528
36874025	181	187	cancer	Disease	MESH:D009369
36874025	246	254	toxicity	Disease	MESH:D064420
36874025	362	365	HCC	Disease	MESH:D006528
36874025	373	382	Crebanine	Chemical	MESH:C061009
36874025	389	410	isoquinoline alkaloid	Chemical	-
36874025	494	500	cancer	Disease	MESH:D009369
36874025	546	555	crebanine	Chemical	MESH:C061009
36874025	564	576	liver cancer	Disease	MESH:D006528
36874025	652	661	crebanine	Chemical	MESH:C061009
36874025	665	668	HCC	Disease	MESH:D006528
36874025	782	791	crebanine	Chemical	MESH:C061009
36874025	795	819	hepatocellular carcinoma	Disease	MESH:D006528
36874025	820	825	HepG2	CellLine	CVCL:0027
36874025	909	918	crebanine	Chemical	MESH:C061009
36874025	943	948	HepG2	CellLine	CVCL:0027
36874025	965	969	CCK8	CellLine	CVCL:2873
36874025	1059	1068	crebanine	Chemical	MESH:C061009
36874025	1072	1077	HepG2	CellLine	CVCL:0027
36874025	1170	1179	crebanine	Chemical	MESH:C061009
36874025	1221	1226	HepG2	CellLine	CVCL:0027
36874025	1240	1253	Hoechst 33258	Chemical	MESH:D006690
36874025	1269	1275	cancer	Disease	MESH:D009369
36874025	1312	1321	crebanine	Chemical	MESH:C061009
36874025	1343	1348	HepG2	CellLine	CVCL:0027
36874025	1413	1418	HepG2	CellLine	CVCL:0027
36874025	1450	1453	ROS	Chemical	MESH:D017382
36874025	1462	1466	JC-1	Chemical	MESH:C068624
36874025	1502	1525	reactive oxygen species	Chemical	MESH:D017382
36874025	1566	1571	HepG2	CellLine	CVCL:0027
36874025	1629	1638	crebanine	Chemical	MESH:C061009
36874025	1676	1682	FoxO3a	Gene	2309
36874025	1686	1692	cancer	Disease	MESH:D009369
36874025	1761	1770	crebanine	Chemical	MESH:C061009
36874025	1901	1904	AKT	Gene	207
36874025	1905	1911	FoxO3a	Gene	2309
36874025	1930	1933	NAC	Chemical	MESH:D000111
36874025	1938	1941	AKT	Gene	207
36874025	1952	1960	LY294002	Chemical	MESH:C085911
36874025	2001	2004	NAC	Chemical	MESH:D000111
36874025	2009	2012	AKT	Gene	207
36874025	2023	2031	LY294002	Chemical	MESH:C085911
36874025	2101	2110	crebanine	Chemical	MESH:C061009
36874025	2139	2148	crebanine	Chemical	MESH:C061009
36874025	2198	2203	HepG2	CellLine	CVCL:0027
36874025	2288	2297	crebanine	Chemical	MESH:C061009
36874025	2319	2324	HepG2	CellLine	CVCL:0027
36874025	2375	2384	crebanine	Chemical	MESH:C061009
36874025	2414	2437	reactive oxygen species	Chemical	MESH:D017382
36874025	2439	2442	ROS	Chemical	MESH:D017382
36874025	2516	2525	crebanine	Chemical	MESH:C061009
36874025	2546	2551	Bcl-2	Gene	596
36874025	2568	2571	Bax	Gene	581
36874025	2581	2585	PARP	Gene	1302
36874025	2595	2604	caspase-3	Gene	836
36874025	2617	2626	caspase-9	Gene	842
36874025	2665	2668	ROS	Chemical	MESH:D017382
36874025	2679	2695	N-acetylcysteine	Chemical	MESH:D000111
36874025	2697	2700	NAC	Chemical	MESH:D000111
36874025	2703	2712	Crebanine	Chemical	MESH:C061009
36874025	2735	2738	AKT	Gene	207
36874025	2745	2751	FoxO3a	Gene	2309
36874025	2776	2784	LY294002	Chemical	MESH:C085911
36874025	2858	2861	AKT	Gene	207
36874025	2862	2868	FoxO3a	Gene	2309
36874025	2891	2894	ROS	Chemical	MESH:D017382
36874025	2933	2936	NAC	Chemical	MESH:D000111
36874025	2988	2997	crebanine	Chemical	MESH:C061009
36874025	3001	3004	AKT	Gene	207
36874025	3009	3015	FoxO3a	Gene	2309
36874025	3092	3101	crebanine	Chemical	MESH:C061009
36874025	3169	3178	cytotoxic	Disease	MESH:D064420
36874025	3190	3214	hepatocellular carcinoma	Disease	MESH:D006528
36874025	3251	3254	ROS	Chemical	MESH:D017382
36874025	3338	3341	HCC	Disease	MESH:D006528
36874025	3350	3353	ROS	Chemical	MESH:D017382
36874025	3354	3357	AKT	Gene	207
36874025	3358	3364	FoxO3a	Gene	2309
36874025	Association	MESH:C061009	2309
36874025	Negative_Correlation	MESH:C085911	207
36874025	Association	MESH:C061009	207
36874025	Association	207	2309
36874025	Association	MESH:D006528	207
36874025	Association	MESH:D006528	2309
36874025	Association	MESH:C061009	MESH:D017382
36874025	Negative_Correlation	MESH:C061009	MESH:D006528
36874025	Association	MESH:C061009	842
36874025	Association	MESH:D017382	MESH:D006528
36874025	Association	MESH:D017382	842
36874025	Association	MESH:C061009	596
36874025	Negative_Correlation	MESH:C061009	MESH:D009369
36874025	Association	MESH:D006528	842
36874025	Association	MESH:D017382	836
36874025	Negative_Correlation	MESH:D000111	MESH:D006528
36874025	Association	MESH:C061009	1302
36874025	Association	MESH:D006690	MESH:D009369
36874025	Association	MESH:C061009	836
36874025	Association	MESH:C061009	581

